Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Utah Medical Products Inc...

    NASDAQ: UTMD · Real-Time Price · USD
    54.94
    -2.42 (-4.22%)
    At close: Jun 13, 2025, 3:59 PM
    55.16
    0.41%
    After-hours: Jun 13, 2025, 04:04 PM EDT

    Utah Medical Products Statistics

    Share Statistics

    Utah Medical Products has 3.25M shares outstanding. The number of shares has increased by -6.99% in one year.

    Shares Outstanding

    n/a
    		 3.25M

    Shares Change (YoY)

    n/a
    		 -6.99%

    Shares Change (QoQ)

    n/a
    		 -3.24%

    Owned by Institutions (%)

    n/a
    		 66.28%

    Shares Floating

    n/a
    		 3.02M

    Failed to Deliver (FTD) Shares

    n/a
    		 180

    FTD / Avg. Volume

    n/a
    		 1.1%

    Short Selling Information

    The latest short interest is 92.56K, so 2.85% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 92.56K

    Short % of Shares Out

    n/a
    		 2.85%

    Short % of Float

    n/a
    		 3.07%

    Short Ratio (days to cover)

    n/a
    		 8.54

    Valuation Ratios

    The PE ratio is 15.52 and the forward PE ratio is null. Utah Medical Products's PEG ratio is -1.16.

    PE Ratio

    n/a
    		 15.52

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 5.26

    Forward PS

    n/a
    		 1.8

    PB Ratio

    n/a
    		 1.83

    P/FCF Ratio

    n/a
    		 0

    PEG Ratio

    n/a
    		 -1.16
    Financial Ratio History

    Enterprise Valuation

    Utah Medical Products has an Enterprise Value (EV) of 132.64M.

    EV / Sales

    n/a
    		 3.24

    EV / EBITDA

    n/a
    		 8.07

    EV / EBIT

    n/a
    		 0

    EV / FCF

    n/a
    		 0

    Financial Position

    The company has a current ratio of 25.64, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 25.64

    Quick Ratio

    n/a
    		 23.29

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 0.02

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is 11.81% and Return on Invested Capital is 9.45%.

    Return on Equity

    n/a
    		 11.81%

    Return on Assets

    n/a
    		 11.32%

    Return on Invested Capital

    n/a
    		 9.45%

    Revenue Per Employee

    n/a
    		 $263,890.32

    Profits Per Employee

    n/a
    		 $89,509.68

    Employee Count

    n/a
    		 155

    Asset Turnover

    n/a
    		 0.33

    Inventory Turnover

    n/a
    		 1.9

    Taxes

    Income Tax

    n/a
    		 2.93M

    Effective Tax Rate

    n/a
    		 17.43%

    Stock Price Statistics

    The stock price has increased by -17.73% in the last 52 weeks. The beta is 0.28, so Utah Medical Products's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.28

    52-Week Price Change

    n/a
    		 -17.73%

    50-Day Moving Average

    n/a
    		 54.13

    200-Day Moving Average

    n/a
    		 60.79

    Relative Strength Index (RSI)

    n/a
    		 49.11

    Average Volume (20 Days)

    n/a
    		 16,390

    Income Statement

    In the last 12 months, Utah Medical Products had revenue of 40.9M and earned 13.87M in profits. Earnings per share was 3.96.

    Revenue

    n/a
    		 40.9M

    Gross Profit

    n/a
    		 24.14M

    Operating Income

    n/a
    		 13.59M

    Net Income

    n/a
    		 13.87M

    EBITDA

    n/a
    		 16.44M

    EBIT

    n/a
    		 13.59M

    Earnings Per Share (EPS)

    n/a
    		 3.96
    Full Income Statement

    Balance Sheet

    The company has 82.98M in cash and 282K in debt, giving a net cash position of 82.69M.

    Cash & Cash Equivalents

    n/a
    		 82.98M

    Total Debt

    n/a
    		 282K

    Net Cash

    n/a
    		 82.69M

    Retained Earnings

    n/a
    		 129.3M

    Total Assets

    n/a
    		 122.52M

    Working Capital

    n/a
    		 92.08M
    Full Balance Sheet

    Cash Flow

    Operating Cash Flow

    n/a
    		 n/a

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 n/a

    FCF Per Share

    n/a
    		 0
    Full Cash Flow Statement

    Margins

    Gross margin is 59.03%, with operating and profit margins of 33.23% and 33.92%.

    Gross Margin

    n/a
    		 59.03%

    Operating Margin

    n/a
    		 33.23%

    Pretax Margin

    n/a
    		 41.08%

    Profit Margin

    n/a
    		 33.92%

    EBITDA Margin

    n/a
    		 40.19%

    EBIT Margin

    n/a
    		 33.23%

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    UTMD pays an annual dividend of $1.22, which amounts to a dividend yield of 2.12%.

    Dividend Per Share

    n/a
    		 $1.22

    Dividend Yield

    n/a
    		 2.12%

    Dividend Growth (YoY)

    n/a
    		 1.67%

    Payout Ratio

    n/a
    		 32.06%

    Earnings Yield

    n/a
    		 6.44%

    FCF Yield

    n/a
    		 0%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for UTMD.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 $24.04

    Lynch Upside

    n/a
    		 -56.24%

    Graham Number

    n/a
    		 54.66

    Graham Upside

    n/a
    		 -0.51%

    Stock Splits

    The last stock split was on Mar 22, 1993. It was a forward split with a ratio of 3:2.

    Last Split Date

    n/a
    		 Mar 22, 1993

    Split Type

    n/a
    		 forward

    Split Ratio

    n/a
    		 3:2

    Scores

    Altman Z-Score

    n/a
    		 22.94

    Piotroski F-Score

    n/a
    		 6

    Add to Watchlist